Everforth Inc quarterly report, Q1 FY2014

On Assignment, Inc. — Q1 2014 Form 10-Q

Entity note: The request identifies Everforth Inc, but the supplied filing is for On Assignment, Inc. The filing covers the three months ended March 31, 2014 and is unaudited; results are not necessarily indicative of full-year performance.

Business context and results

On Assignment provides contract, contract-to-hire, and direct-hire staffing in technology, healthcare, and life sciences. Its reportable segments were Apex, Oxford, Physician, and Life Sciences Europe. The company realigned its former Life Sciences segment during the quarter and retrospectively restated prior-period segment information.

MetricQ1 2014Q1 2013
Revenue$439.3 million$379.0 million
Gross profit / margin$137.6 million / 31.3%$110.1 million / 29.0%
Operating income / margin$27.3 million / 6.2%$22.9 million / 6.0%
Income from continuing operations$14.0 million$10.2 million
Net income$13.9 million$24.6 million
Diluted EPS$0.25$0.46
Net cash from operating activities$(4.3) million$3.6 million

Material changes and operating drivers

  • Revenue rose 15.9%; management cited 9.4% organic growth and $24.7 million of revenue from the 2013 Whitaker and CyberCoders acquisitions. Pro forma revenue growth, assuming both acquisitions at the start of 2012, was 9.8%.
  • Apex revenue increased 16.1%, including a 13.9% increase in average contract professionals on assignment. Oxford revenue grew 14.4%, but was down about 2.5% excluding CyberCoders, partly due to completion of a large prior-year project. Physician revenue rose 20.9%, but declined 6.8% excluding Whitaker amid lower government and some long-term client demand. Life Sciences Europe revenue increased 12.5%.
  • Gross margin expanded about 230 basis points, mainly from a greater mix of direct-hire and conversion fees, including CyberCoders. SG&A rose to 23.7% of revenue from 21.6%, partly reflecting CyberCoders’ higher expense margin; it included $0.8 million of acquisition, integration, and strategic-planning costs.
  • Net income fell year over year because Q1 2013 included a $14.4 million after-tax gain on the sale of Nurse Travel. Continuing-operations income increased. Q1 2014 included a $0.1 million loss from discontinued operations.

Cash, debt, and liquidity

  • Cash was $23.4 million at March 31, down from $37.4 million at year-end; $8.1 million was held outside the United States and management said it did not intend to repatriate it. Working capital was $190.5 million.
  • Operating cash use was $4.3 million, including working-capital outflows from business growth and a $10.4 million tax payment related to the Allied Healthcare sale. Capital expenditures were $4.0 million. Management estimated full-year 2014 capital expenditures of approximately $19.7 million.
  • Total debt was $393.8 million, including $18.3 million current debt; the weighted-average interest rate was 2.8%. The company ended the quarter with $81.0 million available on its revolving facility and a funded-debt-to-EBITDA ratio of 2.12:1, within covenant limits.
  • In February, the company shifted $82.5 million of borrowing from the Term B to the Term A facility; management estimated annual interest savings of about $1.0 million. Management said working capital, revolver availability, and expected operating cash flows should cover the next 12 months’ needs.

Outlook, risks, and contingencies

  • No specific revenue or earnings guidance was provided. Management noted staffing demand is historically lower in the first and fourth quarters and usually stronger in the second and third; first-quarter service costs are also affected by payroll-tax resets.
  • Key stated risks include economic-driven demand, attracting and retaining staffing consultants and qualified professionals, competition, managing growth and systems, acquisition integration, litigation and malpractice exposures, and execution of the five-year strategic plan.
  • Debt covenants restrict, among other matters, additional debt, acquisitions, asset sales, and dividends; the maximum leverage covenant tightens from 4.00:1 at March 31, 2014 to 3.25:1 by June 30, 2015. Debt is secured by substantially all company assets. A hypothetical 100-basis-point rate change would alter annual interest expense by approximately $3.9 million before interest-rate-cap effects.
  • Potential contingent consideration for acquisitions was approximately $16.0 million through 2015; the recorded fair-value liability was $7.9 million. Acquisition purchase-price allocations remained subject to finalization, and estimates depend on acquired-business performance.
  • The company had accrued approximately $2.1 million to settle an alleged class action concerning nurse pay during its ownership of Nurse Travel. It also reported a $1.6 million reserve for uncertain tax positions and ordinary-course legal matters; management did not expect pending matters to have a material effect.
  • Management reported effective disclosure controls and no material change in internal control over financial reporting during the quarter. It expected adoption of ASU 2014-08 on discontinued-operation reporting not to have a material effect.

Important facts for investors to verify

  • Confirm the issuer identity: the supplied filing is for On Assignment, Inc., not Everforth Inc.
  • Assess how much reported growth and margin expansion depends on the CyberCoders and Whitaker acquisitions and their integration.
  • Monitor operating cash conversion, receivables, and the impact of tax payments and other working-capital movements.
  • Track debt paydown, covenant headroom, interest-rate exposure, and contingent acquisition payments.
  • Review the nurse-pay settlement, the discontinued-operation insurance claim, and any updates to acquisition purchase accounting or legal contingencies.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.